Company TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 HKD | +6.33% | +8.39% | -14.72% |
03-15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
Business Summary
Number of employees: 552
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Anti-tumor Drugs and Self-developed Biological Drugs
100.0
%
| 92 | 100.0 % | 514 | 100.0 % | +458.99% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 85 | 92.3 % | 514 | 100.0 % | +505.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Liu
CEO | Chief Executive Officer | 56 | 16/10/16 |
Ben Xiao
DFI | Director of Finance/CFO | 42 | 31/12/21 |
Ming Liu
CTO | Chief Tech/Sci/R&D Officer | 63 | 27/08/17 |
Director/Board Member | 65 | 04/07/10 | |
Shan Feng
LAW | General Counsel | 45 | 30/11/14 |
Yi Fan Chen
SEC | Corporate Secretary | 44 | 30/04/20 |
Wing Yat Lui
SEC | Corporate Secretary | 35 | 15/04/19 |
Chi-Yuen Wu
PRN | Corporate Officer/Principal | 52 | 31/12/15 |
Chun-Ming Lin
SAM | Sales & Marketing | 50 | 31/12/15 |
Xiaobao Chen
PRN | Corporate Officer/Principal | 42 | 19/06/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 04/07/10 | |
Hong Jen Chang
BRD | Director/Board Member | 68 | 11/03/19 |
Shan Fu
CHM | Chairman | 56 | 18/01/16 |
Jun Liu
CEO | Chief Executive Officer | 56 | 16/10/16 |
Lan Hu
BRD | Director/Board Member | 53 | 11/03/19 |
Wei Dong Liu
BRD | Director/Board Member | 56 | 11/08/23 |
De Qian Wang
BRD | Director/Board Member | 73 | 11/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 772,787,887 | 448,300,187 ( 58.01 %) | 0 | 58.01 % |
Company contact information
TOT BIOPHARM International Co. Ltd.
No.120 Changyang Street Suzhou Industrial Park
, Suzhou
+
http://www.totbiopharm.comSector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.72% | 166M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 1875 Stock
- Company TOT BIOPHARM International Company Limited